Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in the relapse setting: two case reports and a review of the literature

Creative Commons License

Yılmaz M., Eskazan A. E., Unsal A., Tanınmıs H., Kara E., Cetıner M., ...Daha Fazla

TRANSFUSION, cilt.53, sa.7, ss.1586-1593, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 53 Sayı: 7
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1111/j.1537-2995.2012.03944.x
  • Dergi Adı: TRANSFUSION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1586-1593
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Hayır

Özet

Background: Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease, characterized by microangiopathic hemolytic anemia, thrombocytopenia, fever, neurologic disturbances, and renal failure. Plasma therapy has dramatically improved prognosis of TTP, whereas recurrent acute episodes still occur in approximately 40% of patients. Moreover, patients with acquired ADAMTS13 deficiency, which is a significant factor for relapse, may require additional immunosuppressive treatment to get a durable remission.